Sign in

CIK 0001636651

  • Non-accelerated filer
  • Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465270895
Phone
+1 212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-26 ALEXANDER MARGARET A. President and CEO Grant or award · Employee Stock Option (Right to Buy) +1,435,000 1,435,000
2026-02-23 ALEXANDER MARGARET A. President and CEO Sale −11,656 $1.45 $17K 61,750
2026-01-04 ALEXANDER MARGARET A. President and CEO Grant or award · Employee Stock Option (right to buy) +890,000 890,000
2025-02-26 ALEXANDER MARGARET A. President and COO Sale −5,279 $0.56 $3K 73,406
2025-02-20 ALEXANDER MARGARET A. President and COO Grant or award +43,750 78,685
2025-02-20 ALEXANDER MARGARET A. President and COO Grant or award · Employee Stock Option (Right to Buy) +262,500 262,500
2025-01-27 ALEXANDER MARGARET A. President and COO Purchase +6,810 $0.73 $5K 34,935
2024-09-09 ALEXANDER MARGARET A. President and COO Grant or award · Employee Stock Option (right to buy) +140,000 140,000

Page 1 of 1 · 8 trades